Cost-effectiveness thresholds play a vital role in healthcare decision-making, helping to ensure that NHS resources are used ...

New analysis presented by the company, together with an improved discount to the price of vamorolone, mean that NICE can now ...

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Public involvement is important, expected and possible in all types of health and social care research.

Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...

There is a simple discount patient access scheme for bevacizumab gamma. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

A list of downloadable documents created during development.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Crizotinib (Xalkori, Pfizer) is indicated for 'the treatment of adults with ROS1-positive advanced non-small cell lung cancer (NSCLC)'. The list price is £4,689.00 per 60‑capsule pack of 200 mg or 250 ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...